Related Experiment Video
Updated: Aug 9, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Novel double heterozygous mutations on Met306Val and Thr181Asn related to a hereditary coagulation factor VII
Chuan-qing Tu1, Chun-yan Deng, Jian-zeng Wu
1Department of Heamatology, Bao'an People's Hospital, Shenzhen 518101, China.
Insights
Genetic analysis revealed double heterozygous mutations (Met306Val and Thr181Asn) in the coagulation factor VII (FVII) gene of a Chinese patient with hereditary FVII deficiency. The novel Met306Val mutation may alter FVII protein structure and function.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Hereditary factor VII (FVII) deficiency is a rare bleeding disorder.
- Identifying the genetic basis of FVII deficiency is crucial for diagnosis and management.
Observation:
- A Chinese family with hereditary FVII deficiency was studied.
- The proband, a 15-year-old female, and her family members underwent genetic analysis.
- DNA sequencing identified double heterozygous mutations in the FVII gene of the proband.
Findings:
- The proband presented with compound heterozygous mutations: Met306Val and Thr181Asn in the FVII gene.
- The Met306Val mutation was inherited from the mother and elder sister.
- The Thr181Asn mutation was inherited from the father.
Implications:
- The Met306Val substitution is a novel mutation associated with hereditary FVII deficiency.
- Molecular modeling suggests Met306Val may cause steric hindrance, altering FVII protein configuration and function.
- These findings contribute to understanding the genetic heterogeneity of FVII deficiency.
Objective:
To identify the genetic defect of coagulation factor VII in a Chinese family with hereditary FVII deficiency.
Methods:
Peripheral blood samples were collected from the proband of hereditary FVII deficiency, female, aged 15, 4 members of her family, and 100 healthy persons. Genomic DNA was isolated. All the exons and exon-intron boundaries of FVII gene were amplified by PCR, then the PCR products were sequenced by direct sequencing. Restrictive endonuclease analysis was performed in all of the family members and the 100 healthy donors to exclude gene polymorphism. Biostructural analysis of the mutated FVII was completed by molecular modeling.
Results:
Double heterozygous mutations in the proband were identified: A-->G mutation at position 10833 and C-->A mutation at position 9643, resulting in Met306Val and Thr181Asn substitution respectively. Heterozygosity for Met306Val was confirmed in the proband's mother and her elder sister; heterozygosity for Thr181Asn was confirmed in the proband's father. It was found by computer simulated molecular model that the Met306Val replacement, which was located on the surface of the FVII molecule, might cause steric hindrance and change the configuration and function of FVII protein.
Conclusion:
Double heterozygous mutations for Met306Val and Thr181Asn in FVII gene have been found in a proband with hereditary FVII deficiency. The Met306Val substitution in FVII gene is a novel mutation in hereditary FVII deficiency. The heterozygous mutation of FVII gene may change the configuration of FVII protein and result in FVII dysfunction.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Point and Frameshift Mutations
Single Nucleotide Polymorphisms-SNPs
Mutations in Microorganisms
Animal Mitochondrial Genetics
Pleiotropy

